Journal Article

Proteopathic tau seeding predicts tauopathy in vivo

Hilda Mirbaha, Thomas E. Mahan, Larisa Belaygorod, Tritia R. Yamasaki, Brandon B. Holmes, Nigel J. Cairns, Marc I. Diamond, David M. Holtzman, William C. Eades, Jennifer L. Furman

2014

Overview

Transcellular propagation of protein aggregates, or proteopathic seeds, may drive the progression of neurodegenerative diseases in a prion-like manner. In tauopathies such as Alzheimer’s disease, this model predicts that tau seeds propagate pathology through the brain via cell–cell transfer in neural networks. The critical role of tau seeding activity is untested, however. It is unknown whether seeding anticipates and correlates with subsequent development of pathology as predicted for a causal agent. One major limitation has been the lack of a robust assay to measure proteopathic seeding activity in biological specimens. We engineered an ultrasensitive, specific, and facile FRET-based flow cytometry biosensor assay based on expression of tau or synuclein fusions to CFP and YFP, and confirmed its sensitivity and specificity to tau (∼300 fM) and synuclein (∼300 pM) fibrils. This assay readily discriminates Alzheimer’s disease vs. Huntington's disease and aged control brains. We then carried out a detailed time-course study in P301S tauopathy mice, comparing seeding activity versus histological markers of tau pathology, including MC1, AT8, PG5, and Thioflavin S. We detected robust seeding activity at 1.5 mo, >1 mo before the earliest histopathological stain. Proteopathic tau seeding is thus an early and robust marker of tauopathy, suggesting a proximal role for tau seeds in neurodegeneration. Significance Prion-like propagation of proteopathic seeds may underlie the progression of neurodegenerative diseases, including the tauopathies and synucleinopathies. We aimed to construct a versatile and simple cell assay to sensitively and specifically detect proteopathic seeding activity. Using a combination of FRET flow cytometry and a tau monoclonal FRET biosensor cell line, we report seed detection in the femtomolar range. This assay is easily applied to human brain homogenates and selectively responds to Alzheimer's disease but not Huntington's disease brains. By comparing seeding activity in a mouse model of human tauopathy, we demonstrate detection of proteopathic seeding far in advance of standard histopathological markers. Proteopathic seeding is thus an early marker of tauopathy, consistent with a causal role for tau seeds in neurodegeneration.

• Publisher: National Academy of Sciences,National Acad Sciences
• Subject: Aging - pathology / Alzheimer disease / Alzheimer Disease - metabolism / Alzheimer Disease - pathology / Alzheimer's disease / animal models / Animals / Biological Sciences / Biomarkers - metabolism / Biosensing Techniques / Biosensors / brain / Cells, Cultured / Disease Models, Animal / Flow Cytometry / Fluorescence Resonance Energy Transfer / HEK293 Cells / histopathology / Humans / Mice, Transgenic / Mutant Proteins - metabolism / Neural networks / neurodegenerative diseases / Pathology / PNAS Plus / Protein Aggregation, Pathological - metabolism / Protein Aggregation, Pathological - pathology / Protein Binding / Proteins / Rodents / Seeding / seeds / sowing / tau Proteins - metabolism / Tauopathies - metabolism / Tauopathies - pathology